1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Opsens Inc.
  6. Financials
    OPS   CA6838231083

OPSENS INC.

(OPS)
  Report
Delayed Toronto Stock Exchange  -  05/16 01:25:59 pm EDT
1.770 CAD   -2.21%
04/26OpSens Announces Health Canada Approval For Its New TAVR Guidewire
MT
04/26Opsens announces health canada approval for its new tavr guidewire
AQ
04/26Opsens Inc. Announces Health Canada Approval for Its New TAVR Guidewire
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: August 2019 2020 2021 2022 2023 2024
Capitalization1 74,870,4282196--
Enterprise Value (EV)1 74,870,4282196196196
P/E ratio -41,5x-26,0x-264x-26,8x60,3x20,1x
Yield ------
Capitalization / Revenue 2,28x2,39x8,20x5,36x3,61x3,77x
EV / Revenue 2,28x2,39x8,20x5,36x3,61x3,77x
EV / EBITDA -83,0x-35,7x343x-42,2x40,3x24,5x
Price to Book ------
Nbr of stocks (in thousands) 90 11090 280106 988108 427--
Reference price (CAD) 0,830,782,641,811,811,81
Announcement Date 11/14/201911/19/202011/23/2021---
1 CAD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: August 2019 2020 2021 2022 2023 2024
Net sales1 32,829,534,536,654,452,1
EBITDA1 -0,90-1,980,82-4,654,878,00
Operating profit (EBIT)1 -1,95-3,64-0,95-6,574,626,10
Operating Margin -5,96%-12,4%-2,76%-18,0%8,51%11,7%
Pre-Tax Profit (EBT)1 -1,95-2,64-1,13-7,282,235,60
Net income1 -1,95-2,64-1,15-7,291,705,60
Net margin -5,96%-8,98%-3,34%-19,9%3,12%10,7%
EPS2 -0,02-0,03-0,01-0,070,030,09
Dividend per Share ------
Announcement Date 11/14/201911/19/202011/23/2021---
1 CAD in Million
2 CAD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: August 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales1 8,078,108,109,6010,910,0
EBITDA1 -0,86-1,44-1,82-1,26-0,671,10
Operating profit (EBIT)1 -1,31-1,89-2,27-1,72-1,220,60
Operating Margin -16,2%-23,4%-28,1%-17,9%-11,2%6,00%
Pre-Tax Profit (EBT)1 -1,20-2,06-2,40-2,00-1,200,50
Net income1 -1,22-2,09-2,40-2,00-1,200,50
Net margin -15,1%-25,8%-29,7%-20,8%-11,0%5,00%
EPS2 -0,01-0,02-0,02-0,02-0,010,01
Dividend per Share ------
Announcement Date 11/23/202101/13/202204/13/2022---
1 CAD in Million
2 CAD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: August 2019 2020 2021 2022 2023 2024
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow1 --2,212,09-7,002,305,30
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share2 ----0,040,06-
Capex1 0,701,220,751,201,602,00
Capex / Sales 2,15%4,14%2,17%3,28%2,94%3,84%
Announcement Date 11/14/201911/19/202011/23/2021---
1 CAD in Million
2 CAD
Previous periodNext period
Estimates
Key data
Capitalization (CAD) 196 252 940
Capitalization (USD) 151 759 956
Net sales (CAD) 34 464 000
Net sales (USD) 26 698 066
Number of employees 163
Sales / Employee (CAD) 211 436
Sales / Employee (USD) 163 792
Free-Float 95,0%
Free-Float capitalization (CAD) 186 474 043
Free-Float capitalization (USD) 144 198 057
Avg. Exchange 20 sessions (CAD) 246 956
Avg. Exchange 20 sessions (USD) 191 309
Average Daily Capital Traded 0,13%
EPS & Dividend